These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30390725)

  • 61. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital.
    Apaydin R; Bilen N; Dökmeci S; Bayramgürler D; Yildirim G
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):518-20. PubMed ID: 11444283
    [No Abstract]   [Full Text] [Related]  

  • 62. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future.
    Lehloenya RJ; Dheda K
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):475-86. PubMed ID: 22512756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions.
    Halevy S; Cohen AD; Grossman N
    J Am Acad Dermatol; 2005 Feb; 52(2):254-61. PubMed ID: 15692470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Incidence and severity of cutaneous adverse effects of drugs].
    Zawodnik S; Saurat JH
    Ann Med Interne (Paris); 1984; 135(8):630-2. PubMed ID: 6241437
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
    Jarjour S; Barrette M; Normand V; Rouleau JL; Dubé MP; de Denus S
    Pharmacogenomics; 2015; 16(7):755-67. PubMed ID: 25965122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
    Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
    J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Skin diseases among elderly patients attending skin clinic at the Regional Dermatology Training Centre, Northern Tanzania: a cross-sectional study.
    Mponda K; Masenga J
    BMC Res Notes; 2016 Feb; 9():119. PubMed ID: 26905256
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical-epidemiological profile of severe cutaneous drug reactions in children in Abidjan (Côte d'Ivoire)].
    Kourouma HS; Kouassi YI; Diabaté A; Sangaré A; Ecra EJ; Kaloga M; Gbery IP; Kouassi A; Kassi K; Yoboué YP
    Bull Soc Pathol Exot; 2014 Aug; 107(3):142-5. PubMed ID: 24792460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The usefulness of skin tests to prove drug hypersensitivity.
    Lammintausta K; Kortekangas-Savolainen O
    Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cutaneous adverse drug reactions in a hospital-based Chinese population.
    Huang HY; Luo XQ; Chan LS; Cao ZH; Sun XF; Xu JH
    Clin Exp Dermatol; 2011 Mar; 36(2):135-41. PubMed ID: 20738322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
    Scheinfeld N
    J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia].
    Gamba C; Schroeder J; Citterio A; Cazzaniga S; Rivolta AL; Vighi G;
    Recenti Prog Med; 2014 Oct; 105(10):379-84. PubMed ID: 25282350
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.
    Sharma S; Jayakumar D; Palappallil DS
    Indian Dermatol Online J; 2019; 10(5):547-554. PubMed ID: 31544074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between serum ferritin and the severity of drug eruptions.
    Pan Y; Tang S; Zheng S; Li S; Zhu D; Fang H; Qiao J
    J Clin Lab Anal; 2020 Feb; 34(2):e23043. PubMed ID: 31556160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients.
    Müller FH
    Rofo; 2014 Nov; 186(11):1028-34. PubMed ID: 24729407
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Allergic cutaneous reactions to drugs.
    Bigby M; Stern RS; Arndt KA
    Prim Care; 1989 Sep; 16(3):713-27. PubMed ID: 2529577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cutaneous reactions to drugs].
    Mulder WM; Meinardi MM; Bruynzeel DP
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.